FDA Approves Bizengri for Targeted Therapy in Advanced Pancreatic and Lung Cancer Merus has achieved a significant milestone with the FDA’s accelerated approval of Bizengri (zenocutuzumab-zbco), making it the first-ever approved treatment for advanced pancreatic adenocarcinoma and ...

www.linkedin.com/pulse/fda-ap...

FDA Approves Bizengri for Targeted Therapy in Advanced Pancreatic and Lung Cancer

kstrategyand.com/pharma-news

#Bizengri #FDAApproval #AdvancedPancreaticCancer #NSCLC #CancerTreatment #TargetedTherapy #NRG1GeneFusion #Humanteconomy #Humantec #KStrategyand